Cyprus Mail
Asia World

WHO gives emergency approval to Sinopharm, first Chinese jab

people rest after receiving a dose of china's sinopharm coronavirus disease (covid 19) vaccine at a sport centre in stip
People rest after receiving a dose of China's Sinopharm coronavirus disease (COVID-19) vaccine at a sport centre, as the country continues its mass inoculation campaign, in Stip, North Macedonia

The World Health Organization announced on Friday it had approved a COVID-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use.

The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO’s backing.

It is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease.

A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries.

The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna.

Related posts

UK’s Raab: No doubt some countries are using vaccines a geopolitical tool

G7 preparations hit by covid-19 outbreak, hotel closed

Biden meets Britain’s Johnson, to warn over N. Irish peace (Update)

Reuters News Service

Skull and crossbones sign given to unvaccinated in rural India

Variants can evade antibodies by spreading via supercells

Thousands of Greeks protest ‘monstrous’ labour reform bill